Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state in which AD has minimal impact on the patient’s life by achieving pre-agreed disease control goals through the use of an appropriate systemic therapy. Prof. Dr. med. Schmid-Grendelmeier gave a practice-oriented overview of the MDA concept in his presentation.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment
SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes
- Wearables: screening via smartwatch?
New study on atrial fibrillation in high-risk patients
- Planning a Family, Pregnancy, and Breastfeeding
Update on Anti-Rheumatic Medications
- Peristomal skin health
Focus on preventive care options
- Mental Health with GLP-1 RAs